![PDF) The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients: A 2-Year Follow-up | Ruth Pat-Horenczyk, Salomon Stemmer, Shlomit Perry, and Yaira Hamama-raz - Academia.edu PDF) The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients: A 2-Year Follow-up | Ruth Pat-Horenczyk, Salomon Stemmer, Shlomit Perry, and Yaira Hamama-raz - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/39039791/mini_magick20190223-2406-h6948t.png?1550956202)
PDF) The Effectiveness of Group Intervention on Enhancing Cognitive Emotion Regulation Strategies in Breast Cancer Patients: A 2-Year Follow-up | Ruth Pat-Horenczyk, Salomon Stemmer, Shlomit Perry, and Yaira Hamama-raz - Academia.edu
![NBER Twitter પર: "Sources of high end-of-life spending for cancer patients, from @danzeltzer, Liran Einav, Amy Finkelstein, Tzvi Shir, Salomon M. Stemmer, and Ran D. Balicer https://t.co/vyosdFbT3M https://t.co/VsajwVZKrx" / Twitter NBER Twitter પર: "Sources of high end-of-life spending for cancer patients, from @danzeltzer, Liran Einav, Amy Finkelstein, Tzvi Shir, Salomon M. Stemmer, and Ran D. Balicer https://t.co/vyosdFbT3M https://t.co/VsajwVZKrx" / Twitter](https://pbs.twimg.com/media/EopmDGjW4AI36Jp.png)
NBER Twitter પર: "Sources of high end-of-life spending for cancer patients, from @danzeltzer, Liran Einav, Amy Finkelstein, Tzvi Shir, Salomon M. Stemmer, and Ran D. Balicer https://t.co/vyosdFbT3M https://t.co/VsajwVZKrx" / Twitter
Prospective Long-Term Follow-Up of Pulmonary Diffusion Capacity Reduction Caused by Dose-Dense Chemotherapy in Patients with Breast Cancer
![Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire](https://mms.businesswire.com/media/20191104005226/en/753988/23/4096453_3004008_Can-Fite_logo.jpg)
Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
![Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis](https://www.mdpi.com/cancers/cancers-12-03026/article_deploy/html/images/cancers-12-03026-g003.png)
Cancers | Free Full-Text | Comparison of Poly (ADP-ribose) Polymerase Inhibitors (PARPis) as Maintenance Therapy for Platinum-Sensitive Ovarian Cancer: Systematic Review and Network Meta-Analysis
![Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology](https://www.frontiersin.org/files/Articles/499663/fonc-10-00191-HTML/image_m/fonc-10-00191-g002.jpg)
Frontiers | miR-125a Induces HER2 Expression and Sensitivity to Trastuzumab in Triple-Negative Breast Cancer Lines | Oncology
![COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/08/F210804YS11.jpg)
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
![Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study | SpringerLink Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11060-021-03911-7/MediaObjects/11060_2021_3911_Fig1_HTML.png)
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study | SpringerLink
![Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy | Cancer Discovery Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy | Cancer Discovery](https://cancerdiscovery.aacrjournals.org/content/candisc/11/9/2158/F2.large.jpg)
Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy | Cancer Discovery
![Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire](https://mms.businesswire.com/media/20200316005169/en/633723/23/Can-Fite_logo_no_shadow_%5B1%5D.jpg)
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
![Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-017-0033-7/MediaObjects/41523_2017_33_Fig1_HTML.jpg)